Delivery Order SPE2DB22D3004-SPE2DB25FQ67D
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Lisdexamfetamine 40 mg capsules (90-count units) with a contract ceiling value of $1,339.45. This is a firm fixed price delivery order with no set-aside designation, issued competitively to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The place of performance is located at the contractor's corporate office in Conshohocken, PA, with an...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100-count units) valued at $5,911.41. This is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100-count units) with a ceiling value of $20,729.23. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement to support...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Lisdexamfetamine capsules 30mg, with a ceiling value of $4,474.11. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The order is due for completion by August 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,280.64 by the Defense Logistics Agency Medical Supply Chain on August 13, 2025, with an ultimate completion date of August 14, 2025. The contract calls for the supply of Lisdexamfetamine 20 mg capsules in quantities of 100, to be delivered to Conshohocken, Pennsylvania. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Lisdexamfetamine 50 mg capsules (90-count units) valued at $1,057.44. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award practices. The delivery order is due for completion by September 15, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 9, 2025, for the supply of Lisdexamfetamine 20 mg capsules in quantities of 100 units. This is a firm fixed price delivery order with a ceiling value of $2,832.60 and an ultimate completion date of September 10, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Lisdexamfetamine 50 mg capsules (100-count units) with a ceiling value of $7,920.33. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 10, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Lisdexamfetamine 70 mg capsules (100 count) valued at $1,426.80. The contract is a firm fixed-price delivery order with a completion date of August 8, 2025, and carries no set-aside designation, indicating it was awarded through open competition. This order will be fulfilled at the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,977.61 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 30 mg capsules (100 count) on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order was issued under a child contract arrangement with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FQ67DDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 10, 2025, by the Defense Logistics Agency (DLA) for Lisdexamfetamine 40 mg capsules (90-count supply). This is a firm fixed price, non-competitive set-aside delivery order with a ceiling value of $1,394.96 and an ultimate completion date of September 11, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally. The DLA Medical Supply Chain utilizes prime vendor contracts as a strategic procurement vehicle to ensure reliable access to critical medications and medical commodities across multiple therapeutic domains for defense and veteran healthcare systems. AmerisourceBergen's substantial IDC demonstrates the company's capacity to fulfill federal pharmaceutical procurement requirements at scale, serving diverse military and government healthcare customers including the Defense Health Agency and U.S. Coast Guard. As a child delivery order under the larger SPE2DX vehicle, this award reflects routine pharmaceutical replenishment activities supporting ongoing military medical operations and healthcare readiness across the defense enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/10/25 |